Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1444668 | 0.87 | CXCR3 (0.62) | EPHX2 | |
| SCHEMBL4010729 | 0.85 | EPHX2 (0.78) | EPHX2 | |
| SCHEMBL3347934 | 0.85 | EPHX2 (1.00) | EPHX2 | |
| SCHEMBL20041093 | 0.84 | EPHX2 (0.72) | EPHX2USP30 | |
| SCHEMBL3346367 | 0.83 | EPHX2 (0.79) | EPHX2 | |
| SCHEMBL4011037 | 0.83 | EPHX2 (0.79) | EPHX2 | |
| SCHEMBL4016622 | 0.83 | EPHX2 (0.72) | EPHX2USP30 | |
| SCHEMBL4997818 | 0.83 | EPHX2 (0.79) | EPHX2 | |
| SCHEMBL4009460 | 0.82 | EPHX2 (0.78) | EPHX2 | |
| SCHEMBL2717167 | 0.82 | EPHX2 (1.00) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010053829-A1 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS | ARETE THERAPEUTICS, INC. (US) | 2010-05-14 | — | — | WO | disclosed |